Drug price increases layered over decades: AARP analysis shows how list prices can rise by more than 700%

A new AARP analysis released Thursday shows how list prices for the 25 top Medicare Part D drugs increased by an average of 226% since they first entered the market, making the need clear for the upcoming government drug price negotiations and ongoing inflation-related rebates, the retirees’ group said.

Click here to view original post